Literature DB >> 20590400

Structural MRI findings in long-term cannabis users: what do we know?

Valentina Lorenzetti1, Dan I Lubman, Sarah Whittle, Nadia Solowij, Murat Yücel.   

Abstract

In animal studies, tetrahydrocannabinol (THC) has been found to affect brain morphology, particularly within areas rich in cannabinoid receptors (e.g., hippocampus, cerebral cortex). While cannabis remains the most widely used illicit drug worldwide, there has been limited work investigating its effects on human brain tissue. In this paper, we conducted a systematic review of existing structural magnetic resonance imaging studies to examine whether cannabis use is associated with significant changes in brain anatomy. We identified only 13 structural neuroimaging studies, which were diverse in terms of sample characteristics (e.g., age of participants, duration and frequency of use) and methodology (e.g., image analysis). No study found global structural changes in cannabis users, although six studies reported regional alterations. While changes in the hippocampus and parahippocampus were frequently identified, the findings were inconsistent across studies. The available literature also provides some evidence that regional structural changes are associated with cannabis use patterns (particularly cumulative dosage and frequency of use), as well as measures of psychopathology (e.g., measures of depressive and psychotic symptoms). Together, these structural imaging findings suggest that THC exposure does affect brain morphology, especially in medial-temporal regions. Given the small literature available and the limitations of studies to date, further research is clearly required, particularly given the prevalence of cannabis use worldwide.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20590400     DOI: 10.3109/10826084.2010.482443

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  45 in total

1.  Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users.

Authors:  Joseph P Schacht; Kent E Hutchison; Francesca M Filbey
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

2.  Reflection impulsivity in adolescent cannabis users: a comparison with alcohol-using and non-substance-using adolescents.

Authors:  Nadia Solowij; Katy A Jones; Megan E Rozman; Sasha M Davis; Joseph Ciarrochi; Patrick C L Heaven; Nicole Pesa; Dan I Lubman; Murat Yücel
Journal:  Psychopharmacology (Berl)       Date:  2011-09-21       Impact factor: 4.530

3.  White matter integrity differences associated with post-traumatic stress disorder are not normalized by concurrent marijuana use.

Authors:  Chien-Lin Yeh; Nina Levar; Hannah C Broos; Alyson Dechert; Kevin Potter; A Eden Evins; Jodi M Gilman
Journal:  Psychiatry Res Neuroimaging       Date:  2019-11-14       Impact factor: 2.376

Review 4.  Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives.

Authors:  Alison C Burggren; Anaheed Shirazi; Nathaniel Ginder; Edythe D London
Journal:  Am J Drug Alcohol Abuse       Date:  2019-07-31       Impact factor: 3.829

Review 5.  Reward, Control & Decision-Making in Cannabis Use Disorder: Insights from Functional MRI.

Authors:  Hudaisa Fatima; Allyn C Howlett; Christopher T Whitlow
Journal:  Br J Radiol       Date:  2019-08-09       Impact factor: 3.039

6.  Brain Volume Correlates with Duration of Abstinence from Substance Abuse in a Region-Specific and Substance-Specific Manner.

Authors:  Cole Korponay; David S Kosson; Jean Decety; Kent A Kiehl; Michael Koenigs
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-10

7.  Long-term effects of marijuana use on the brain.

Authors:  Francesca M Filbey; Sina Aslan; Vince D Calhoun; Jeffrey S Spence; Eswar Damaraju; Arvind Caprihan; Judith Segall
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

Review 8.  Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations.

Authors:  Benedikt Fischer; Cayley Russell; Pamela Sabioni; Wim van den Brink; Bernard Le Foll; Wayne Hall; Jürgen Rehm; Robin Room
Journal:  Am J Public Health       Date:  2017-06-23       Impact factor: 9.308

9.  The adverse health effects and harms related to marijuana use: an overview review.

Authors:  K Ally Memedovich; Laura E Dowsett; Eldon Spackman; Tom Noseworthy; Fiona Clement
Journal:  CMAJ Open       Date:  2018-08-16

10.  Grey Matter Volume Differences Associated with Extremely Low Levels of Cannabis Use in Adolescence.

Authors:  Catherine Orr; Philip Spechler; Zhipeng Cao; Matthew Albaugh; Bader Chaarani; Scott Mackey; Deepak D'Souza; Nicholas Allgaier; Tobias Banaschewski; Arun L W Bokde; Uli Bromberg; Christian Büchel; Erin Burke Quinlan; Patricia Conrod; Sylvane Desrivières; Herta Flor; Vincent Frouin; Penny Gowland; Andreas Heinz; Bernd Ittermann; Jean-Luc Martinot; Marie-Laure Paillère Martinot; Frauke Nees; Dimitri Papadopoulos Orfanos; Tomáš Paus; Luise Poustka; Sabina Millenet; Juliane H Fröhner; Rajiv Radhakrishnan; Michael N Smolka; Henrik Walter; Robert Whelan; Gunter Schumann; Alexandra Potter; Hugh Garavan
Journal:  J Neurosci       Date:  2019-01-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.